Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

01-08-2017 | Book Review

Valentina Ambrosini and Stefano Fanti (eds): Clinicians’ Guides to Radionuclide Hybrid Imaging: PET/CT in Neuroendocrine Tumors

Springer International Publishing Switzerland, 2016, ISBN: 978-3-319-29202-1

Authors: Manuela Amato, Luigi Mansi

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 8/2017

Excerpt

PET/CT in Neuroendocrine Tumors is part of a collection of 15 light booklets published by Springer under the auspices of the British Nuclear Medicine Society. The title of the series is “Clinicians’ Guides to Radionuclide Hybrid Imaging” and the editors are J.B. Bomanji, G. Gnanasegaran, S. Fanti and H.A. Macapinlac. This book is edited by two international experts in the field: Valentina Ambrosini and Stefano Fanti, from the University of Bologna. …

Title: Valentina Ambrosini and Stefano Fanti (eds): Clinicians’ Guides to Radionuclide Hybrid Imaging: PET/CT in Neuroendocrine Tumors
Springer International Publishing Switzerland, 2016, ISBN: 978-3-319-29202-1
Authors: Manuela Amato
Luigi Mansi
Publication date: 01-08-2017
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 8/2017
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-017-3630-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Valentina Ambrosini and Stefano Fanti (eds): Clinicians’ Guides to Radionuclide Hybrid Imaging: PET/CT in Neuroendocrine Tumors

Springer International Publishing Switzerland, 2016, ISBN: 978-3-319-29202-1

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 8/2017

Preclinical imaging characteristics and quantification of Platinum-195m SPECT

Semi-quantitative scoring of skeletal metastases by 123I-mIBG scintigraphy in high-risk neuroblastoma

Is the information provided by amino acid PET radiopharmaceuticals clinically equivalent in gliomas?

[18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis

Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients

Risk-stratifying capacity of PET/CT metabolic tumor volume in stage IIIA non-small cell lung cancer